DEC1 Anticorps
(Deleted in Esophageal Cancer 1 (DEC1))
Candidate tumor supressor.
antibodies-online.com est synonyme de produits de recherche de haute qualité. Cherchez, trouvez et commandez des outils avec des données de validation étendues, des images, des références. Notre service clientèle scientifique est toujours à votre disposition si vous avez des questions sur la sélection ou l'application de nos produits.
Catégories DEC1 en vedette
DEC1 Anticorps
High quality antibodies with extensive validation data.
DEC1 recommandé Anticorps
Produit
Reactivity
Application
Validations
N° du produit
Quantité
Fiche technique
Reactivity
Human
Application
WB, IP, IHC (fp)
Validations
N° du produit
ABIN7454653
Quantité
100 μg
Fiche technique
Fiche technique
Reactivity
Human
Application
WB
Validations
- (1)
N° du produit
ABIN5027144
Quantité
100 μg
Fiche technique
Fiche technique
Reactivity
Human
Application
WB, IP
Validations
N° du produit
ABIN2252137
Quantité
100 μL
Fiche technique
Fiche technique
Dernières publications sur nos produits DEC1
: "Smad3 Suppresses Epithelial Cell Migration and Proliferation via the Clock Gene Dec1, Which Negatively Regulates the Expression of Clock Genes Dec2 and Per1." dans: The American journal of pathology, Vol. 189, Issue 4, pp. 773-783, (2019) (PubMed).: "Bhlhe40 mediates tissue-specific control of macrophage proliferation in homeostasis and type 2 immunity." dans: Nature immunology, Vol. 20, Issue 6, pp. 687-700, (2019) (PubMed).
: "Differentiated embryo chondrocyte plays a crucial role in DNA damage response via transcriptional regulation under hypoxic conditions." dans: PLoS ONE, Vol. 13, Issue 2, pp. e0192136, (2018) (PubMed).
: "Mice lacking the transcriptional regulator Bhlhe40 have enhanced neuronal excitability and impaired synaptic plasticity in the hippocampus." dans: PLoS ONE, Vol. 13, Issue 5, pp. e0196223, (2018) (PubMed).
: "Bhlhe40 is an essential repressor of IL-10 during Mycobacterium tuberculosis infection." dans: The Journal of experimental medicine, Vol. 215, Issue 7, pp. 1823-1838, (2018) (PubMed).
: "DEC1 negatively regulates the expression of CXCL10 and CCL5 induced by poly IC in normal human mesangial cells." dans: Biomedical research (Tokyo, Japan), Vol. 38, Issue 4, pp. 249-255, (2018) (PubMed).
: "DEC1 promotes hypoxia-induced epithelial-mesenchymal transition (EMT) in human hepatocellular carcinoma cells." dans: Biomedical research (Tokyo, Japan), Vol. 38, Issue 4, pp. 221-227, (2018) (PubMed).
: "DEC2 expression antagonizes cisplatin‑induced apoptosis in human esophageal squamous cell carcinoma." dans: Molecular medicine reports, Vol. 16, Issue 1, pp. 43-48, (2017) (PubMed).
: "Smad3 and Bmal1 regulate p21 and S100A4 expression in myocardial stromal fibroblasts via TNF-α." dans: Histochemistry and cell biology, Vol. 148, Issue 6, pp. 617-624, (2017) (PubMed).
: "IL-1-induced Bhlhe40 identifies pathogenic T helper cells in a model of autoimmune neuroinflammation." dans: The Journal of experimental medicine, Vol. 213, Issue 2, pp. 251-71, (2016) (PubMed).
Synonymes et noms alternatifs relatifs à DEC1
deleted in esophageal cancer 1 (DEC1), CTS9, DEC1Protein level used designations for DEC1
- candidate tumor suppressor CTS9
- deleted in esophageal cancer 1
Vous êtes ici:
